These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19465930)

  • 1. Inhibitors paradoxically prime kinases.
    Frye SV; Johnson GL
    Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule discrimination map of the antibiotic resistance kinome.
    Shakya T; Stogios PJ; Waglechner N; Evdokimova E; Ejim L; Blanchard JE; McArthur AG; Savchenko A; Wright GD
    Chem Biol; 2011 Dec; 18(12):1591-601. PubMed ID: 22195561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.
    Breen ME; Soellner MB
    ACS Chem Biol; 2015 Jan; 10(1):175-89. PubMed ID: 25494294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from molecular scaffold analysis.
    Hu Y; Stumpfe D; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1742-53. PubMed ID: 21755989
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of FDA-approved small molecule protein kinase inhibitors.
    Roskoski R
    Pharmacol Res; 2019 Jun; 144():19-50. PubMed ID: 30877063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for pharmacological targeting of pseudokinases.
    Kung JE; Jura N
    Nat Rev Drug Discov; 2019 Jul; 18(7):501-526. PubMed ID: 30850748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ins and outs of selective kinase inhibitor development.
    Müller S; Chaikuad A; Gray NS; Knapp S
    Nat Chem Biol; 2015 Nov; 11(11):818-21. PubMed ID: 26485069
    [No Abstract]   [Full Text] [Related]  

  • 9. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
    Dimova D; Bajorath J
    Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the Protein Kinase Conformational Space with Machine Learning.
    Ung PM; Rahman R; Schlessinger A
    Cell Chem Biol; 2018 Jul; 25(7):916-924.e2. PubMed ID: 29861272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of targeted libraries against the human Chk1 kinase using PGVL Hub.
    Peng Z; Hu Q
    Methods Mol Biol; 2011; 685():321-36. PubMed ID: 20981531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination.
    Rudolf AF; Skovgaard T; Knapp S; Jensen LJ; Berthelsen J
    PLoS One; 2014; 9(6):e98800. PubMed ID: 24915177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure.
    Park H; Chi O; Kim J; Hong S
    J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-assisted small-molecule screening against protein kinases.
    Inglés-Prieto Á; Reichhart E; Muellner MK; Nowak M; Nijman SM; Grusch M; Janovjak H
    Nat Chem Biol; 2015 Dec; 11(12):952-4. PubMed ID: 26457372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.
    Urich R; Wishart G; Kiczun M; Richters A; Tidten-Luksch N; Rauh D; Sherborne B; Wyatt PG; Brenk R
    ACS Chem Biol; 2013 May; 8(5):1044-52. PubMed ID: 23534475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.
    Vijayan RS; He P; Modi V; Duong-Ly KC; Ma H; Peterson JR; Dunbrack RL; Levy RM
    J Med Chem; 2015 Jan; 58(1):466-79. PubMed ID: 25478866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
    Verkhivker GM
    Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SnapShot: Kinase Inhibitors I.
    Wang J; Gray NS
    Mol Cell; 2015 May; 58(4):708.e1. PubMed ID: 26000854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SnapShot: Kinase Inhibitors II.
    Wang J; Gray NS
    Mol Cell; 2015 May; 58(4):710.e1. PubMed ID: 26000855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.